LYKOS THERAPEUTICS for LYKOS THERAPEUTICS
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating innovative mental health challenges, including PTSD (no bill); Fiscal Year 2026 Military Construction, Veterans Affairs and Related Agencies Appropriations Act (issues related to therapeutics and implementation research and development) (no bill number).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KACY HUTCHISON | — |
Defense DEF
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating innovative mental health challenges, including PTSD (no bill); Fiscal Year 2026 Military Construction, Veterans Affairs and Related Agencies Appropriations Act (issues related to therapeutics and implementation research and development) (no bill number).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KACY HUTCHISON | — |
Health Issues HCR
Fiscal Year 2026 Commerce, Justice, Science and Related Agencies Appropriations Act (issues related to potential improvements to Food & Drug Administration and Drug Enforcement Administration processes for rescheduling of controlled substances) (no bill number).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KACY HUTCHISON | — |
Veterans VET
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating innovative mental health challenges, including PTSD (no bill); Fiscal Year 2026 Military Construction, Veterans Affairs and Related Agencies Appropriations Act (issues related to therapeutics and implementation research and development) (no bill number).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KACY HUTCHISON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.